• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析生物参数与异种移植肿瘤模型治疗反应之间统计关系的新标准。

New criteria for analyzing the statistical relationships between biological parameters and therapeutic responses of xenografted tumor models.

机构信息

Departement d'Oncologie Medicale, Hopital Europeen Georges Pompidou, AP-HP, 20, rue Leblanc, 75015, Paris, France.

出版信息

Contemp Clin Trials. 2012 Jan;33(1):178-83. doi: 10.1016/j.cct.2011.09.010. Epub 2011 Oct 1.

DOI:10.1016/j.cct.2011.09.010
PMID:21986388
Abstract

Analysis of preclinical studies using human tumors xenografted into rodents is commonly performed with Tumor Growth Index (TGI) and Tumor Growth Delay index (TGDi). To circumvent the limitations of these parameters, two new parameters, Time To Relapse (TTR) and Tumor Growth Speed (TGS), were developed using a mathematical modeling approach based on an exponential tumor growth. TTR is similar to progression free survival used in human clinical trials and TGS characterizes the pattern of tumor cell proliferation. Parameters were estimated for each rodent by the maximum likelihood method and statistical analyses were performed using ANOVA. These criteria can be used when tumor growths are assessed by repeated measures of their volume. As an example, we used data from a previously published study, which aimed to evaluate the relationship between histology, genetic parameters, and response to alkylating agents in a series of twelve gliomas. The group treated with temozolomide was reanalyzed using our criteria. This group presented a significantly longer TTR than the control group. TTR was also different according to tumor type: oligodendrogliomas relapsed later than glioblastomas. The TGS was different according to the tumor type. Loss of heterozygosity (LOH) 1p ± 19q, LOH 10p ± 10q, telomerase activity, PTEN mutation, and EGFR amplification were related to temozolomide efficacy. Our criteria provide additional information to those given by TGI and TGDi. Due to statistical properties of TTR and TGS, some relations between the parameters such as tumor type or genetic alterations can be studied with TTR and TGS and not with TGI or TGDi.

摘要

使用异种移植入啮齿动物的人类肿瘤进行临床前研究的分析通常使用肿瘤生长指数(TGI)和肿瘤生长延迟指数(TGDi)进行。为了规避这些参数的局限性,我们采用基于指数肿瘤生长的数学建模方法开发了两个新的参数,即复发时间(TTR)和肿瘤生长速度(TGS)。TTR 类似于人类临床试验中使用的无进展生存期,而 TGS 则描述了肿瘤细胞增殖的模式。通过最大似然法估计每个啮齿动物的参数,并通过方差分析进行统计分析。当通过重复测量肿瘤体积来评估肿瘤生长时,可以使用这些标准。例如,我们使用先前发表的一项研究的数据,该研究旨在评估一系列 12 个神经胶质瘤中组织学、遗传参数与烷化剂反应之间的关系。使用我们的标准重新分析了接受替莫唑胺治疗的组。该组的 TTR 明显长于对照组。根据肿瘤类型,TTR 也有所不同:少突胶质细胞瘤比胶质母细胞瘤复发时间晚。TGS 根据肿瘤类型而不同。杂合性缺失(LOH)1p±19q、LOH 10p±10q、端粒酶活性、PTEN 突变和 EGFR 扩增与替莫唑胺疗效相关。我们的标准提供了 TGI 和 TGDi 给出的信息之外的更多信息。由于 TTR 和 TGS 的统计特性,TTR 和 TGS 可用于研究某些参数之间的关系,例如肿瘤类型或遗传改变,而 TGI 或 TGDi 则不行。

相似文献

1
New criteria for analyzing the statistical relationships between biological parameters and therapeutic responses of xenografted tumor models.分析生物参数与异种移植肿瘤模型治疗反应之间统计关系的新标准。
Contemp Clin Trials. 2012 Jan;33(1):178-83. doi: 10.1016/j.cct.2011.09.010. Epub 2011 Oct 1.
2
Prognostic stratification of patients with anaplastic gliomas according to genetic profile.根据基因特征对间变性胶质瘤患者进行预后分层。
Cancer. 2006 Oct 15;107(8):1891-7. doi: 10.1002/cncr.22211.
3
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
4
Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status.α-连接蛋白在神经胶质瘤中的表达:与组织学类型以及 1p、19q、10p 和 10q 状态的关系。
J Clin Pathol. 2011 Sep;64(9):793-801. doi: 10.1136/jcp.2010.087668. Epub 2011 Jun 8.
5
A mathematical model to study the effects of drugs administration on tumor growth dynamics.一种用于研究药物给药对肿瘤生长动力学影响的数学模型。
Math Biosci. 2006 Apr;200(2):127-51. doi: 10.1016/j.mbs.2005.12.028. Epub 2006 Mar 3.
6
[Histological and molecular classification of gliomas].[胶质瘤的组织学和分子分类]
Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):505-15. doi: 10.1016/j.neurol.2008.03.011. Epub 2008 Jun 10.
7
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.组织学和1p/19q状态在间变性少突胶质细胞瘤中的预后影响
Cancer. 2005 Oct 1;104(7):1468-77. doi: 10.1002/cncr.21338.
8
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.单克隆抗体806可抑制表达de2-7或扩增型表皮生长因子受体(EGFR)的肿瘤异种移植物的生长,但对野生型EGFR无效。
Cancer Res. 2001 Jul 15;61(14):5355-61.
9
Survival analysis of presumptive prognostic markers among oligodendrogliomas.少突胶质细胞瘤中假定预后标志物的生存分析。
Cancer. 2005 Oct 15;104(8):1693-9. doi: 10.1002/cncr.21362.
10
Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.人类少突胶质细胞瘤中1号、10号和19号染色体异常的分子分析:杂合性缺失频率与分级、年龄及性别的关系
Clin Neuropathol. 2006 Jan-Feb;25(1):18-24.

引用本文的文献

1
Improved drug-screening tests of candidate anti-cancer drugs in patient-derived xenografts through use of numerous measures of tumor growth determined in multiple independent laboratories.通过使用多个独立实验室确定的多种肿瘤生长测量方法,改进了在患者来源的异种移植模型中对候选抗癌药物的药物筛选测试。
PLoS One. 2025 Jun 18;20(6):e0324141. doi: 10.1371/journal.pone.0324141. eCollection 2025.
2
Antitumor Activity of Intratumoral Ethanol Injection in an Orthotopic Pancreatic Cancer Cell Mouse Xenograft Model.原位胰腺癌细胞小鼠异种移植模型中瘤内注射乙醇的抗肿瘤活性
Gastroenterol Res Pract. 2018 Feb 21;2018:7149565. doi: 10.1155/2018/7149565. eCollection 2018.
3
Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies.
NOD/SCID IL-2Rγ(null) 小鼠的胫骨内注射人多发性骨髓瘤细胞可模拟人类骨髓瘤,并成为开发抗癌策略的有价值工具。
PLoS One. 2013 Nov 6;8(11):e79939. doi: 10.1371/journal.pone.0079939. eCollection 2013.